On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.

Shondra Pruett-Miller has taken many paths in her career with her love of genome editing always as a guiding light.

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

Data Mining Software for Genomics, Proteomics and Expression Data (Part 1) Data Mining Software for Genomics, Proteomics and Expression Data (Part 2) High-throughput (HT) sequencing, microarray screening and protein expression profiling technologies drive discovery efforts in today's genomics and proteomics laboratories. These tools allow researchers to generate massive amounts of data, at a rate orders of magnitude greater than scientists ever anticipated. Initiatives to sequence entire genom

Splitting Chinook salmon into two groups based on their DNA could aid conservation efforts. But some researchers argue that this would be a misuse of the data.

To conduct this survey, The Scientist invited 1800 readers via E-mail to respond to a web-based survey form. There were a total of 220 responses from March 2 to 12, 2001, a response rate of 12.2%. Have you held research positions in both academia and industry? (Positions may include graduate research, industrial internships, or any other research positions - paid or unpaid - in both work environments).   Percent Count Answers 72.6% 159/219 Yes 27.4% 60/219 No

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.